StonvexLoading…
StonvexStonvexStonvexCore line items from IMNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $6.94M | $9.04M | $14.02M |
Operating Income | $-224.11M | $-305.80M | $-109.53M |
Net Income | $-212.39M | $-292.96M | $-106.81M |
EPS (Diluted) | $-2.43 | $-5.00 | $-5.38 |
Total Assets | $683.19M | $240.24M | $148.54M |
Total Liabilities | $48.84M | $59.08M | $28.66M |
Cash & Equivalents | $653.48M | $143.35M | $98.68M |
Free Cash Flow OCF − CapEx | $-200.60M | $-117.97M | $-8.40M |
Shares Outstanding | 113.13M | 64.46M | 43.25M |